<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="30/04/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9731208" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9731208</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">An <term sem="Organic_compound_other" id="T1" lex="allosteric_drug">allosteric drug</term>, <term sem="Organic_compound_other" id="T2" lex="o,o&apos;-bismyristoyl_thiamine_disulfide">o,o&apos;-bismyristoyl thiamine disulfide</term>, suppresses <term sem="Other" id="T3" lex="HIV-1_replication"><term sem="Virus" id="T4" lex="HIV-1">HIV-1</term> replication</term> through prevention of <term sem="Other" id="T5" lex="nuclear_translocation">nuclear translocation</term> of both <term sem="Protein_molecule" id="T6" lex="HIV-1_Tat"><term sem="Virus" id="T7" lex="HIV-1">HIV-1</term> <term sem="Protein_molecule" id="A1">Tat</term></term> and <term sem="Protein_complex" id="T8" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="E4" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, <clueType>suppresses</clueType> HIV-1 replication <linkCause>through</linkCause> prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="E5" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, <clueType>suppresses</clueType> HIV-1 replication <linkCause>through</linkCause> prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E3">
<type class="Viral_life_cycle" />
<theme idref="T4" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 <clueType>replication</clueType> through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="T2" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through <clueType>prevention</clueType> <linkTheme>of</linkTheme> nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E5">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="T2" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through <clueType>prevention</clueType> <linkTheme>of</linkTheme> nuclear translocation of both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E6">
<type class="Localization" />
<theme idref1="A1" idref="T7" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 Tat and NF-kappa B.</clue>
</event>
<event id="E7">
<type class="Localization" />
<theme idref1="T8" idref="T7" />
<clue>An allosteric drug, o,o&apos;-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 Tat and NF-kappa B.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The efficacy of <term sem="Organic_compound_other" id="T9" lex="o,o&apos;-bismyristoyl_thiamine_disulfide">o,o&apos;-bismyristoyl thiamine disulfide</term> (<term sem="Organic_compound_other" id="T10" lex="BMT">BMT</term>) was examined in detail against <term sem="Virus" id="T11" lex="HIV-1_laboratory_isolates"><term sem="Virus" id="T12" lex="HIV-1">HIV-1</term> laboratory isolates</term> (<term sem="Virus" id="T13" lex="HTLV-IIIB">HTLV-IIIB</term>, <term sem="Virus" id="T14" lex="JRFL">JRFL</term>, and <term sem="Virus" id="T15" lex="MN">MN</term>), <term sem="Virus" id="T16" lex="primary_isolate">primary isolates</term> (<term sem="Virus" id="T17" lex="KMT">KMT</term> and <term sem="Virus" id="T18" lex="KMO">KMO</term>), and <term sem="Virus" id="T19" lex="simian_immunodeficiency_virus">simian immunodeficiency virus</term> (<term sem="Virus" id="T20" lex="SIVmac251">SIVmac251</term>) in vitro.</sentence>
<event uncertainty="doubtful" id="E8">
<type class="Negative_regulation" />
<theme idref="T13" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event uncertainty="doubtful" id="E9">
<type class="Negative_regulation" />
<theme idref="T14" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event uncertainty="doubtful" id="E10">
<type class="Negative_regulation" />
<theme idref="T15" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> <corefTheme>HIV-1 laboratory isolates</corefTheme> (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event uncertainty="doubtful" id="E11">
<type class="Negative_regulation" />
<theme idref="T17" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), <corefTheme>primary isolates</corefTheme> (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event uncertainty="doubtful" id="E12">
<type class="Negative_regulation" />
<theme idref="T18" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), <corefTheme>primary isolates</corefTheme> (KMT and KMO), and simian immunodeficiency virus (SIVmac251) in vitro.</clue>
</event>
<event uncertainty="doubtful" id="E13">
<type class="Negative_regulation" />
<theme idref="T20" />
<cause idref="T10" />
<clue>The <clueType>efficacy</clueType> <linkCause>of</linkCause> o,o&apos;-bismyristoyl thiamine disulfide (BMT) was examined in detail <linkTheme>against</linkTheme> HIV-1 laboratory isolates (HTLV-IIIB, JRFL, and MN), primary isolates (KMT and KMO), and <corefTheme>simian immunodeficiency virus</corefTheme> (SIVmac251) in vitro.</clue>
</event>
<sentence id="S3"><term sem="Organic_compound_other" id="T21" lex="BMT">BMT</term> inhibited the replication of <term sem="Virus" id="T22" lex="HIV-1">HIV-1</term> in both laboratory and <term sem="Virus" id="T23" lex="primary_isolates">primary isolates</term> in vitro.</sentence>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E19" />
<cause idref="T21" />
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E15">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="T21" />
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="T21" />
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E17">
<type class="Negative_regulation" />
<theme idref="E22" />
<cause idref="T21" />
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="T21" />
<clue>BMT <clueType>inhibited</clueType> the replication of HIV-1 in both laboratory and primary isolates in vitro.</clue>
</event>
<event id="E19">
<type class="Viral_life_cycle" />
<theme idref="T13" />
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T13">HIV-1 in</corefTheme> both <corefTheme idref1="T13">laboratory</corefTheme> and primary <corefTheme idref1="T13">isolates</corefTheme> in vitro.</clue>
</event>
<event id="E20">
<type class="Viral_life_cycle" />
<theme idref="T14" />
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T14">HIV-1 in</corefTheme> both <corefTheme idref1="T14">laboratory</corefTheme> and primary <corefTheme idref1="T14">isolates</corefTheme> in vitro.</clue>
</event>
<event id="E21">
<type class="Viral_life_cycle" />
<theme idref="T15" />
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T15">HIV-1 in</corefTheme> both <corefTheme idref1="T15">laboratory</corefTheme> and primary <corefTheme idref1="T15">isolates</corefTheme> in vitro.</clue>
</event>
<event id="E22">
<type class="Viral_life_cycle" />
<theme idref="T17" />
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T17">HIV-1 in</corefTheme> both laboratory and <corefTheme idref1="T17">primary isolates</corefTheme> in vitro.</clue>
</event>
<event id="E23">
<type class="Viral_life_cycle" />
<theme idref="T18" />
<clue>BMT inhibited the <clueType>replication</clueType> <linkTheme>of</linkTheme> <corefTheme idref1="T18">HIV-1 in</corefTheme> both laboratory and <corefTheme idref1="T18">primary isolates</corefTheme> in vitro.</clue>
</event>
<sentence id="S4">In addition, <term sem="Organic_compound_other" id="T24" lex="BMT">BMT</term> exhibited <term sem="Other" id="T25" lex="antiviral_activity">antiviral activity</term> against <term sem="Virus" id="T26" lex="SIVmac251">SIVmac251</term>.</sentence>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="T26" />
<cause idref="T24" />
<clue>In addition, BMT exhibited <clueType>antiviral activity</clueType> <linkTheme>against</linkTheme> SIVmac251.</clue>
</event>
<sentence id="S5">Minimizing energy studies of <term sem="Organic_compound_other" id="T27" lex="BMT">BMT</term> structure reveal that a <term sem="Organic_compound_other" id="T28" lex="trans-disulfide">trans-disulfide</term> of <term sem="Organic_compound_other" id="T29" lex="thiamine">thiamine</term> (<term sem="Organic_compound_other" id="T30" lex="holo_drug">holo drug</term>) <term sem="Organic_compound_other" id="T31" lex="disulfide">disulfide</term> (<term sem="Organic_compound_other" id="T32" lex="TDS">TDS</term>, <term sem="Organic_compound_other" id="T33" lex="protodrug">protodrug</term>) is allosterically transited to the <term sem="Organic_compound_other" id="T34" lex="reactive_twisted_disulfide">reactive twisted disulfide</term> of <term sem="Organic_compound_other" id="T35" lex="BMT">BMT</term> (<term sem="Organic_compound_other" id="T36" lex="allo_drug">allo drug</term>) by <term sem="Other" id="T37" lex="o,o&apos;-bismyristoyl_esterification">o,o&apos;-bismyristoyl esterification</term> of <term sem="Organic_compound_other" id="T38" lex="TDS">TDS</term>.</sentence>
<sentence id="S6"><term sem="Organic_compound_other" id="T39" lex="BMT">BMT</term> inhibits <term sem="Other" id="T40" lex="nuclear_translocation">nuclear translocation</term> of both <term sem="Protein_molecule" id="T41" lex="HIV-1_transactivator"><term sem="Virus" id="T42" lex="HIV-1">HIV-1</term> transactivator</term> (<term sem="Protein_molecule" id="T43" lex="TAT">TAT</term>) and the <term sem="Protein_molecule" id="T44" lex="cellular_transcriptional_nuclear_factor-KB">cellular transcriptional nuclear factor-KB</term> (<term sem="Protein_complex" id="T45" lex="NF-kappa_B">NF-kappa B</term>), resulting in the suppression of <term sem="Other" id="T46" lex="HIV-1_replication"><term sem="Virus" id="T47" lex="HIV-1">HIV-1</term> replication</term>.</sentence>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E27" />
<cause idref="T39" />
<clue>BMT <clueType>inhibits</clueType> nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="T39" />
<clue>BMT <clueType>inhibits</clueType> nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E27">
<type class="Localization" />
<theme idref1="T43" idref="T42" />
<clue>BMT inhibits <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E28">
<type class="Localization" />
<theme idref1="T45" idref="T42" />
<clue>BMT inhibits <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 replication.</clue>
</event>
<event id="E29">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="E25" />
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), <clueType>resulting in the suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="E26" />
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), <clueType>resulting in the suppression</clueType> <linkTheme>of</linkTheme> HIV-1 replication.</clue>
</event>
<event id="E31">
<type class="Viral_life_cycle" />
<theme idref="T47" />
<clue>BMT inhibits nuclear translocation of both HIV-1 transactivator (TAT) and the cellular transcriptional nuclear factor-KB (NF-kappa B), resulting in the suppression of HIV-1 <clueType>replication</clueType>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
